Medicalgorithmics has a letter of intent regarding the use of AI for the diagnosis of cardiac arrhythmias

Medicalgorithmics has signed a letter of intent with the German company livetec Ingenieurbüro GmbH, in which both parties are considering strategic cooperation on the heart rate monitoring market based on Medicalgorithmics algorithms and software, the company announced.

livetec Ingenieurbüro GmbH (livetec) is a supplier of medical devices used in the diagnosis of heart diseases. The planned cooperation provides for the integration of the PocketECG PC Client platform developed by Medicalgorithmics and the TechBot software, which uses artificial intelligence algorithms for automatic interpretation of the ECG signal, with the “liveECG” solution – a three-channel Holter ECG system, provided by livetec.

“The alliance with the German partner fits perfectly into our development plans as a global provider of artificial intelligence software and services for the medical industry. The combination of the Medicalgorithmics software with the Livetec recorder opens up a new area of business for us, i.e. the use of our algorithms on third-party devices. Our AI-based solutions can improve the diagnostic process while reducing costs,” said Jarosław Jerzakowski, Member of the Management Board for Commercial Affairs at Medicalgorithmics, quoted in the release.

The integration of the Medicalgorithmics software with the liveECG system will open new opportunities for the Polish company in the field of providing proprietary algorithms based on artificial intelligence and ECG signal analysis software for third-party devices, thus creating a new branch of business and revenue stream.

Medicalgorithmics is a high-tech company present on the market since 2005, operating in the field of non-invasive medical devices. The Group strives to become a leading provider of system and algorithmic solutions in cardiological diagnostics, in particular in the field of ECG signal analysis. The company operates in, among others, the USA and Asia. In 2014, the company moved to the main market of the Warsaw Stock Exchange from NewConnect, where it had been listed since 2011. It is included in the sWIG80 index.


Our privacy policy